ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Interventional Cardiology

Top Interventional Cardiology Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SANDEEP CHANDRA MD FACC

Interventional Cardiology

12,163

$751K

670
518 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $61

CLAY CHAPPELL MD

Interventional Cardiology

1,333

$55.4K

172
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 27%

$42
Average prescription price

Avg: $61

DAVID SONG MD FACE

Interventional Cardiology

12,393

$761K

884
770 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $61

JOHN RATHBUN M.D.

Interventional Cardiology

8,191

$384K

666
586 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 27%

$47
Average prescription price

Avg: $61

HAROLD CARLSON MD

Interventional Cardiology

2,787

$190K

303
254 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $61

DIMITRIOS KARMPALIOTIS MD

Interventional Cardiology

886

$61.2K

104
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $61

KENNETH TAYLOR MD

Interventional Cardiology

3,180

$136K

409
339 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 27%

$43
Average prescription price

Avg: $61

AMEEN PERSON M.D.

Interventional Cardiology

738

$36K

184
156 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $61

GARY ELKIN M.D.

Interventional Cardiology

3,666

$172K

284
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 27%

$47
Average prescription price

Avg: $61

DENNIS INCORVATI D.O.

Interventional Cardiology

3,730

$213K

280
240 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $61

BHAGAT REDDY MD

Interventional Cardiology

986

$67.9K

166
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $61

ARTHUR REITMAN M.D.

Interventional Cardiology

4,391

$308K

343
310 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $61

BYRON SIZEMORE M.D.

Interventional Cardiology

3,125

$185K

216
154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $61

SIVA MOHAN M.D.

Interventional Cardiology

1,728

$72.3K

214
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 27%

$42
Average prescription price

Avg: $61

NICHOLAS LEMBO MD

Interventional Cardiology

1,686

$157K

210
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 27%

$93
Average prescription price

Avg: $61

KHUSROW NIAZI MD

Interventional Cardiology

1,116

$89.9K

171
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 27%

$81
Average prescription price

Avg: $61

KULDEEP TALWAR MD

Interventional Cardiology

743

$51.3K

154
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $61

GORDON WALTERS MD

Interventional Cardiology

3,360

$180K

334
293 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $61

ATUL TRIVEDI MD

Interventional Cardiology

1,338

$74.3K

241
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $61

AHMED SHAH MD

Interventional Cardiology

770

$86.8K

84
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 27%

$113
Average prescription price

Avg: $61

GLENN EVANS MD

Interventional Cardiology

4,577

$238K

404
336 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $61

AMOL BAPAT M.D.

Interventional Cardiology

3,970

$312K

311
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $61

CHANDANREDDY DEVIREDDY M.D.

Interventional Cardiology

1,011

$55.4K

114
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $61

DANA EILEN

Interventional Cardiology

573

$32.9K

55
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $61

HOWARD SNAPPER M.D.

Interventional Cardiology

4,432

$277K

370
319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank